Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek C Angus

Showing results (461-470 of 582) with videos related to

Pageof 59
Sort By:
JAMA Network Open|August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisSachin Yende, John A Kellum, Victor B Talisa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19Lana Wahid, Joshua D Froess, Thomas L Ortel, et al.
JCI Insight|December 15, 2020
A road map from single-cell transcriptome to patient classification for the immune response to traumaTianmeng Chen, Matthew J Delano, Kong Chen, et al.
JAMA|July 26, 2018
Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric SepsisIdris V R Evans, Gary S Phillips, Elizabeth R Alpern, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 18, 2018
Traumatic Brain Injury and Infectious Encephalopathy in Children From Four Resource-Limited Settings in AfricaEricka L Fink, Amelie von Saint Andre-von Arnim, Rashmi Kumar, et al.
Critical Care Medicine|February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Annals of the American Thoracic Society|October 13, 2021
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent SepsisKatherine M Reitz, Jason Kennedy, Caroline Rieser, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2024
Randomized Clinical Trial of the Four Supports Intervention for Surrogate Decision-Makers in Intensive Care UnitsRachel A Butler, Jennifer B Seaman, Kristyn Felman, et al.
Critical Care Medicine|December 26, 2009
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisMitchell M Levy, R Phillip Dellinger, Sean R Townsend, et al.
Intensive Care Medicine|January 14, 2010
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisMitchell M Levy, R Phillip Dellinger, Sean R Townsend, et al.
Pageof 59

Showing results (461-470 of 582) with videos related to

Sort By:
Pageof 59
JAMA Network Open|August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisSachin Yende, John A Kellum, Victor B Talisa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 5, 2024
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19Lana Wahid, Joshua D Froess, Thomas L Ortel, et al.
JCI Insight|December 15, 2020
A road map from single-cell transcriptome to patient classification for the immune response to traumaTianmeng Chen, Matthew J Delano, Kong Chen, et al.
JAMA|July 26, 2018
Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric SepsisIdris V R Evans, Gary S Phillips, Elizabeth R Alpern, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 18, 2018
Traumatic Brain Injury and Infectious Encephalopathy in Children From Four Resource-Limited Settings in AfricaEricka L Fink, Amelie von Saint Andre-von Arnim, Rashmi Kumar, et al.
Critical Care Medicine|February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Annals of the American Thoracic Society|October 13, 2021
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent SepsisKatherine M Reitz, Jason Kennedy, Caroline Rieser, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2024
Randomized Clinical Trial of the Four Supports Intervention for Surrogate Decision-Makers in Intensive Care UnitsRachel A Butler, Jennifer B Seaman, Kristyn Felman, et al.
Critical Care Medicine|December 26, 2009
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisMitchell M Levy, R Phillip Dellinger, Sean R Townsend, et al.
Intensive Care Medicine|January 14, 2010
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisMitchell M Levy, R Phillip Dellinger, Sean R Townsend, et al.
Pageof 59